Vanguard Group Inc. Boosts Holdings in Sotera Health (NASDAQ:SHC)

Vanguard Group Inc. grew its position in Sotera Health (NASDAQ:SHCFree Report) by 0.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,565,862 shares of the company’s stock after purchasing an additional 52,802 shares during the quarter. Vanguard Group Inc. owned about 3.38% of Sotera Health worth $161,185,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Element Capital Management LLC acquired a new position in shares of Sotera Health during the third quarter valued at about $1,119,000. Tudor Investment Corp Et Al lifted its stake in shares of Sotera Health by 27.4% during the third quarter. Tudor Investment Corp Et Al now owns 350,487 shares of the company’s stock worth $5,250,000 after buying an additional 75,487 shares during the period. Teachers Retirement System of The State of Kentucky grew its holdings in shares of Sotera Health by 92.8% during the third quarter. Teachers Retirement System of The State of Kentucky now owns 33,890 shares of the company’s stock valued at $507,000 after buying an additional 16,311 shares during the last quarter. Pacer Advisors Inc. increased its position in shares of Sotera Health by 79.4% in the 4th quarter. Pacer Advisors Inc. now owns 14,864 shares of the company’s stock valued at $250,000 after acquiring an additional 6,580 shares during the period. Finally, Allspring Global Investments Holdings LLC raised its stake in Sotera Health by 21.5% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 602,802 shares of the company’s stock worth $10,157,000 after acquiring an additional 106,742 shares during the last quarter. 91.03% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the company. Jefferies Financial Group raised Sotera Health from a “hold” rating to a “buy” rating and increased their price objective for the company from $15.00 to $15.50 in a report on Monday, March 25th. Barclays reduced their price target on shares of Sotera Health from $19.00 to $14.00 and set an “overweight” rating for the company in a research report on Wednesday, April 10th. Citigroup raised shares of Sotera Health from a “neutral” rating to a “buy” rating and dropped their price objective for the company from $18.00 to $16.00 in a report on Wednesday, April 3rd. Finally, Piper Sandler assumed coverage on shares of Sotera Health in a research note on Tuesday, May 21st. They issued a “neutral” rating and a $13.00 price objective on the stock. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $16.92.

Check Out Our Latest Stock Report on SHC

Sotera Health Price Performance

NASDAQ:SHC opened at $11.65 on Thursday. The company has a 50 day moving average price of $11.47 and a 200-day moving average price of $13.39. Sotera Health has a 1-year low of $10.71 and a 1-year high of $19.40. The firm has a market cap of $3.30 billion, a price-to-earnings ratio of 61.32 and a beta of 2.06. The company has a debt-to-equity ratio of 5.39, a current ratio of 3.20 and a quick ratio of 2.86.

Sotera Health (NASDAQ:SHCGet Free Report) last released its quarterly earnings data on Thursday, May 2nd. The company reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Sotera Health had a net margin of 5.09% and a return on equity of 48.47%. The firm had revenue of $248.18 million during the quarter, compared to analysts’ expectations of $254.73 million. Equities research analysts forecast that Sotera Health will post 0.63 EPS for the current year.

Sotera Health Company Profile

(Free Report)

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.

Recommended Stories

Want to see what other hedge funds are holding SHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sotera Health (NASDAQ:SHCFree Report).

Institutional Ownership by Quarter for Sotera Health (NASDAQ:SHC)

Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.